Abstract
Background Muscle wasting is a major concern in ICUs, contributing to morbidity, mortality, and prolonged rehabilitation. While CT-derived L3 Skeletal Muscle Index (L3SMI) assesses core muscle mass, it may not capture peripheral muscle atrophy or fluid-based changes. Point-of-care ultrasound (POCUS) offers a rapid, non-invasive alternative. This study evaluated the prognostic value of POCUS-based muscle measurements compared with L3SMI in predicting mortality, frailty, and functional outcomes.
Methods In this prospective study, 50 critically ill adults meeting Sepsis-3 criteria or requiring respiratory/vasopressor support underwent POCUS assessments of biceps brachii, rectus femoris, and vastus intermedius thickness at days 1, 7, and 14 post-ICU admission. Twenty-eight patients also had CT scans within seven days for L3SMI calculation. The primary outcome was 90-day mortality; secondary outcomes included in-hospital and 30-day mortality, Clinical Frailty Score, and Zubrod/ECOG performance status. Muscle measurements were analyzed both raw and indexed to body surface area, with predictive performance assessed via correlation and ROC analysis.
Results Day 1 biceps brachii thickness strongly predicted in-hospital mortality (AUC 0.84; sensitivity 1.0, specificity 0.67) and retained predictive value for 30-day and 90-day mortality. Vastus intermedius thickness on day 1 was moderately predictive (AUC 0.79). At later time points, larger vastus intermedius measurements correlated negatively with ICU-and ventilator-free days, suggesting edema-related pseudohypertrophy. L3SMI did not significantly correlate with ultrasound-based muscle measurements or clinical outcomes. POCUS-derived peripheral muscle indexing was associated with frailty indices, highlighting its role in capturing meaningful functional deficits.
Conclusion POCUS-based muscle assessments, particularly of the biceps brachii and vastus intermedius, provide valuable prognostic insights beyond conventional L3SMI. While L3SMI remains a core muscle measure, fluid shifts and localized muscle wasting in critical illness may be better captured by ultrasound.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the National Institute of General Medical Sciences, grant # R35GM150695
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was provided by The Penn State College of Medicine Institutional Review Board of the Human Studies Protection Office on Jan 26, 2023 (ref# 15328). All methods were carried out in accordance with relevant institutional guidelines and regulations.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
